COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES USING REAL WORLD DATA FROM BRAZILIAN HEALTH CARE INSURANCE COMPANIES IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE

被引：0
|
作者：
Campagnaro, M. [1 ]
Malard, W. [2 ]
Clemente, V [3 ]
Nunes, A. A. [4 ]
机构：
[1] CSL Vifor, Sao Paulo, SP, Brazil
[2] CSL Vifor, Ribeirao Preto, SP, Brazil
[3] CSL Vifor, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Ribeirao Preto, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE467
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [21] HEALTH CARE COST FOR PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY / ANEMIA BEFORE AND AFTER TREATMENT WITH FERRIC CARBOXYMALTOSE
    Kohls, M.
    Hardt, T.
    Barck, I
    Schultheiss, J.
    Heidler, T.
    Deiters, B.
    VALUE IN HEALTH, 2019, 22 : S554 - S554
  • [22] Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective
    Schwander, Bjoern
    Klesper, Katharina
    Rossol, Siegbert
    Herrmann, Ken
    Zoellner, York Francis
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2024, 16 : 483 - 492
  • [23] Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System
    Bai, Yongrui
    Xu, Yuejuan
    Wu, Bin
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [24] The cost-effectiveness of Tarka in the treatment of heart failure after myocardial infarction in the us health care setting
    Nuijten, M
    Wittenberg, W
    Engelfriet, P
    Engelfriet, P
    VALUE IN HEALTH, 2003, 6 (06) : 655 - 655
  • [25] Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data
    Hong, Sung-Hyun
    Cho, Jeong-Yeon
    Kim, Tae-Bum
    Lee, Eui-Kyung
    Kwon, Sun-Hong
    Shin, Ju-Young
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 1939 - +
  • [26] Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF
    McEwan, Phil
    Ponikowski, Piotr
    Davis, Jason A.
    Rosano, Giuseppe
    Coats, Andrew J. S.
    Dorigotti, Fabio
    O'Sullivan, Donal
    de Arellano, Antonio Ramirez
    Jankowska, Ewa A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (10) : 1687 - 1697
  • [27] Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data
    Elisabeth Brock
    Peter Braunhofer
    Josef Troxler
    Heinz Schneider
    The European Journal of Health Economics, 2014, 15 : 907 - 916
  • [28] Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data
    Brock, Elisabeth
    Braunhofer, Peter
    Troxler, Josef
    Schneider, Heinz
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (09): : 907 - 916
  • [29] Inhaled corticosteroids and brochodilators for severe and very severe COPD patients: Cost-effectiveness and health care budget impact in Italy
    Pradelli, L
    Iannazzo, S
    Dal Negro, RW
    Eandi, M
    VALUE IN HEALTH, 2005, 8 (06) : A212 - A212
  • [30] Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
    Hallinen, Taru
    Kivela, Santtu
    Soini, Erkki
    Harjola, Veli-Pekka
    Pesonen, Mari
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 1 - 13
12345